TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

Kezar Life Sciences Inc (KZR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 68 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KZR
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
263 249 221 199 180 164 145 125 109 98 77 68
244 231 207 186 168 156 137 120 105 95 76 68
28 26 35 33 28 35 42 37 34 39 72 66
237 218 201 180 164 148 132 114 101 90 72 66
– 7.0 2.3 3.1 1.7 1.1 0.4 2.2 2.0 2.0 1.9 –
– 4.4 – – – – 0.5 – – – – –
13 – – – – – – – – – – –
31 33 34 30 29 30 28 22 17 15 6.6 2.8
14 17 18 16 17 20 20 17 14 13 6.6 2.8
2.8 2.9 3.0 4.4 5.9 7.3 8.7 8.9 13 12 2.3 1.4
2.5 3.1 8.3 5.1 2.3 3.5 3.7 2.0 1.2 0.9 0.5 0.3
10.0 10 10 8.8 7.6 6.3 5.1 3.9 2.6 1.4 – –
232 216 188 169 151 134 117 103 92 83 70 65
-295 -319 -351 -372 -394 -414 -434 -451 -465 -476 -491 -496
72 73 73 73 73 73 7.3 7.3 7.3 7.3 7.3 7.3

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?